Cargando…
OR28-05 Approaching Indeterminate Thyroid Nodules in the Absence of Molecular Markers. “The BETH-TR Score”
Context: Given the lack of easy access to molecular markers, for indeterminate thyroid nodules (Bethesda (BETH) category III, IV), the clinician can either decide to get a second opinion from an expert high volume thyroid cytopatholgist, re-do the FNAC after a period of 3-6 months or send the patien...
Autores principales: | Kannan, Subramanian, Khadilkar, Kranti, Siddegowda, Shivaprasad Kumbenahalli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207349/ http://dx.doi.org/10.1210/jendso/bvaa046.2041 |
Ejemplares similares
-
Approaching Indeterminate Thyroid Nodules in the Absence of Molecular Markers: “The BETH-TR Score”
por: Mehta, Sushma, et al.
Publicado: (2020) -
MON-LB75 Stratifying the Risk of Malignancy in Indeterminate Thyroid Nodules
por: Imam, Shahnawaz, et al.
Publicado: (2020) -
Evaluation of LMR, NLR and PLR as predictors of malignancy in indeterminate thyroid nodules
por: Offi, Chiara, et al.
Publicado: (2021) -
OR27-2 Inter-reader Agreement of ATA Sonographic Risk In Thyroid Nodules With Indeterminate Cytology
por: Linares, Maria, et al.
Publicado: (2019) -
Malignancy Risk in RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Real-World Clinical Experience
por: Lu, Joseph, et al.
Publicado: (2021)